Results 71 to 77 of about 237 (77)
Some of the next articles are maybe not open access.

Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China.

Antimicrobial Agents and Chemotherapy, 2018
Jin Shi, Yu Pang, Hairong Huang
exaly  

An overview of new antitubercular drugs, drug candidates, and their targets

Medicinal Research Reviews, 2020
Diwan S Rawat
exaly  

A Prospective, Randomised, Open Label Phase 2b Dose-Finding ​Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

Lilian Tina Minja   +30 more
openaire   +1 more source

Preclinical and Clinical Evaluation of Vancomycin Plus Delpazolid Combination Therapy for Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Multicenter, Double-Blinded, Randomized, Parallel Design, Phase IIa Clinical Trial

Kyung-Hwa Park   +13 more
openaire   +1 more source

Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB Open Access

Journal of Antimicrobial Chemotherapy
Gibson Kibiki   +2 more
exaly  

Sutezolid & Delpazolid - Ein wichtiger Fortschritt bei multiresistenter Tuberkulose

Österreichische Apothekerzeitung
openaire   +1 more source

HIV-associated drug-resistant TB: expanded treatment options and emerging threats

Current Opinion in HIV and AIDS
Alexander W Kay
exaly  
oxazolidinones
humans
linezolid
3. good health
tedizolid
antitubercular agents
sutezolid
drug therapy, combination
adult
previous   6  7  8  

Home - About - Disclaimer - Privacy